ISRCTN15140216Completed未知
A 12-week clinical study to compare a new interactive power toothbrush to an interactive sonic toothbrush in the reduction of gingivitis and plaque
Procter & Gamble (United States)0 sites110 target enrollmentStarted: February 17, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 110
Study Overview
Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33544990/ (added 20/08/2021)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Give written informed consent prior to study participation and be given a signed copy of their informed consent form
- •2. Be at least 18 years of age and typically use a manual toothbrush
- •3. Be in good general health as determined by the investigator/designee based on a review/update of their medical history
- •4. Possess a minimum of 16 natural teeth with facial and lingual scorable surfaces
- •5. Possess a smartphone which runs Android 7.0 to 10.0, or an iPhone that runs on iOS 11.0 to 13.0 and agree to download a toothbrushing app from the manufacturer of the assigned brush. The mobile device must support Bluetooth 4.2 (or higher)/Bluetooth Smart.
- •6. Baseline whole mouth mean MGI score of at least 1.75 but not more than 2.5
- •7. Baseline whole mouth pre-brushing RMNPI score of greater than 0.5
- •8. Have at least 20 but not more than 90 bleeding sites (sites with a score of 1 or 2 on the GBI index) for Baseline whole mouth mean
- •9. Agree not to participate in any other oral care study for the duration of this study
- •10. Agree to not to have any elective dentistry, including dental prophylaxis, until study completion and to report any non-study dentistry received at any time during the course of this study
- •11. Agree to refrain from using any non-study oral hygiene products for the study duration
- •12. Agree to return for all their scheduled visits and to follow all study procedures
- •13. Refrain from brushing their teeth or from performing any other oral hygiene procedure anytime within the 12 hours prior to Baseline Visit and agree to follow these same restrictions prior to all visits
- •14. Refrain from medicated lozenges, breath mints, eating, drinking*, chewing gum and using tobacco for at least 4 hours prior to this visit and agree to follow these same restrictions prior to all visits. *(Allowed small sips of water up until 45 minutes prior to their appointments.)
Exclusion Criteria
- •1. A condition requiring the need for antibiotic premedication prior to dental procedures
- •2. Severe periodontal disease, including but not limited to, purulent exudates, generalized mobility, and/or severe recession
- •3. Teeth that are grossly carious, fully crowned, or extensively restored
- •4. Active treatment for the following conditions: periodontitis, cancer, or a seizure disorder
- •5. Report to be nursing or pregnant, or intend to become pregnant any time during the course of this study
- •6. Taking an antibiotic or using a chlorhexidine mouth rinse any time within the previous 2 weeks
- •7. Have any of the following: orthodontic appliances, removable partial dentures, peri/oral piercings, a pacemaker or other implanted device
- •8. Oral/gum surgery within the previous two months
- •9. Any disease or condition that could possibly interfere with examination/procedures or with the subject’s safe completion of this study
Investigators
Similar Trials
Completed
Not Applicable
Treatment of dark, hyperpigmented patches on human skiMild to moderate hyperpigmentation due to melasma on both sides of the face, but otherwise healthy skinSkin and Connective Tissue DiseasesChloasmaISRCTN97532324Beiersdorf AG60
Completed
Not Applicable
Clinical comparison study between newly developed FFR device based on optical interferometry and conventional FFR devicecoronary artery disease patientsJPRN-UMIN000028268Department of Cardiology Aichi Medical University51
Completed
Not Applicable
A study to compare the effectiveness of a new interactive toothbrush to a manual toothbrush in the reduction of gum disease and plaque over a 12-week periodMild to moderate gingivitisOral HealthGingivitis and periodontal diseasesISRCTN12765864Procter & Gamble (United States)100
Completed
Not Applicable
Anaesthetist-Controlled Compared with Effect-site Patient-maintained Target-controlled Sedation (ACCEPTS)Hip or knee replacementsSurgeryOther joint disordersISRCTN29129799ottingham University Hospitals NHS Trust80
Completed
Not Applicable
Randomised clinical trial comparing the efficacy between metronidazole and Shinus terebinthifolius Raddi (called aroeira) in vaginal use for the treatment of bacterial vaginosisInfections and InfestationsBacterial vaginosisISRCTN18987156Institute for Maternal/Infant Health (IMIP) (Brazil)277